Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies

Details for Australian Patent Application No. 2010236168 (hide)

Owner GENENTECH, INC.

Inventors Dornan, David; Burington, Bart

Agent Griffith Hack

Pub. Number AU-A-2010236168

PCT Pub. Number WO2010/121231

Priority 61/170,615 18.04.09 US

Filing date 17 April 2010

Wipo publication date 21 October 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/121231 Priority application(s): WO2010/121231

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236169-Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function

2010236162-Method of treating disorders associated with protein kinase CK2 activity